Mephyton and Dyspnea exacerbated - a phase IV clinical study of FDA data

Summary:

Dyspnea exacerbated is reported as a side effect among people who take Mephyton (phytonadione), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Zofran, and have Cystic fibrosis.

The phase IV clinical study analyzes which people have Dyspnea exacerbated when taking Mephyton. It is created by eHealthMe based on reports of 1,001 people who have side effects when taking Mephyton from the FDA, and is updated regularly.

What is Mephyton?

Mephyton has active ingredients of phytonadione. eHealthMe is studying from 1,006 Mephyton users. Check the latest studies of Mephyton.

What is Dyspnea exacerbated?

Dyspnea exacerbated is found to be associated with 3,273 drugs and 1,653 conditions by eHealthMe. Check the latest studies of Dyspnea exacerbated.

On Jul, 09, 2026

1,001 people reported to have side effects when taking Mephyton.
Among them, 76 people (7.59%) have Dyspnea exacerbated.

Could Mephyton cause Dyspnea exacerbated?

Among these 76 people:

How long have people been on Mephyton when they have Dyspnea exacerbated? *

What is the gender of people who have Dyspnea exacerbated when taking Mephyton? *

female: 52.05 %
male: 47.95 %

What is the age of people who have Dyspnea exacerbated when taking Mephyton? *

What are other drugs people take besides Mephyton? *

What are other side effects people have besides Dyspnea exacerbated? *

Chest Pain: 36 people, 47.37%
Fatigue (feeling of tiredness): 29 people, 38.16%
Diarrhea: 24 people, 31.58%
Pain: 23 people, 30.26%
Nausea (feeling of having an urge to vomit): 23 people, 30.26%
Abdominal Pain: 20 people, 26.32%
Pneumonia: 20 people, 26.32%
Stress And Anxiety: 20 people, 26.32%
Decreased Interest: 17 people, 22.37%
Weakness: 17 people, 22.37%

What are the existing conditions these people have? *

Cystic Fibrosis (disease of the secretary glands): 25 people, 32.89%
Nausea (feeling of having an urge to vomit): 12 people, 15.79%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 9 people, 11.84%
Constipation: 9 people, 11.84%
High Blood Pressure: 8 people, 10.53%
Itching: 8 people, 10.53%
Metastases To Bone (cancer spreads to bone): 7 people, 9.21%
Stress And Anxiety: 5 people, 6.58%
Acute Lymphocytic Leukemia (All) (cancer of the white blood cells characterized by excess lymphoblasts): 5 people, 6.58%
Nausea And Vomiting: 5 people, 6.58%

* Approximation only. Some reports may have incomplete information.

Do you take Mephyton and have Dyspnea exacerbated?

- Check whether Dyspnea exacerbated is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Mephyton:

Mephyton (1,006 reports)

Browse all side effects of Mephyton:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Dyspnea exacerbated:

Dyspnea exacerbated (3,273 drugs)

Browse all the conditions that are associated with Dyspnea exacerbated:

Dyspnea exacerbated (1,653 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on phytonadione (the active ingredients of Mephyton) and Mephyton (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.